Molecular imaging in patients with mood disorders: A review of PET findings

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 38, Issue 7, 2011, Pages 1367-1380

  Chen, Qiaozhen ^a,b,c   Liu, Weibo ^a   Li, Huichun ^a   Zhang, Hong ^a,b,c   Tian, Mei ^d  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

^c Key Laboratory of Medical Molecular Imaging of Zhejiang Province   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Bipolar disorder; Human; Major depressive disorder; Molecular imaging; Mood disorders; Neurotransmitter; Positron emission tomography

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; FLUORODEOXYGLUCOSE F 18; FLUOXETINE; FLUVOXAMINE; LITHIUM; NEUROTRANSMITTER; RADIOLIGAND; SEROTONIN 1A RECEPTOR; SEROTONIN 2A RECEPTOR; SERTRALINE; SETOPERONE; VALPROATE SEMISODIUM; VENLAFAXINE;

AMYGDALOID NUCLEUS; BIPOLAR DEPRESSION; BRAIN BLOOD FLOW; BRAIN REGION; BRAIN STEM; CINGULATE GYRUS; COGNITIVE THERAPY; CROSS-SECTIONAL STUDY; DRUG EFFECT; FRONTAL CORTEX; GLUCOSE METABOLISM; HUMAN; LONGITUDINAL STUDY; MAJOR DEPRESSION; MANIA; MENTAL PATIENT; MOLECULAR IMAGING; MOOD DISORDER; NEUROIMAGING; NONHUMAN; OCCIPITAL CORTEX; ORBITAL CORTEX; PARIETAL CORTEX; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PROTEIN BINDING; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TREATMENT RESPONSE;

CEREBROVASCULAR CIRCULATION; DOPAMINE; HUMANS; MOOD DISORDERS; NEUROTRANSMITTER AGENTS; POSITRON-EMISSION TOMOGRAPHY; SEROTONIN;

EID: 79958070703     PISSN: 16197070     EISSN: 16197089     Source Type: Journal    
DOI: 10.1007/s00259-011-1779-z     Document Type: Review

References (80)

1. RC Kessler P Berglund O Demler R Jin KR Merikangas EE Walters 2005 Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication Arch Gen Psychiatry 62 6 593 602 15939837 10.1001/archpsyc.62.6.593 (Pubitemid 40973434)
2. MR Phillips J Zhang Q Shi Z Song Z Ding S Pang, et al. 2009 Prevalence, treatment, and associated disability of mental disorders in four provinces in China during 2001-05: an epidemiological survey Lancet 373 9680 2041 2053 19524780 10.1016/S0140-6736(09)60660-7
3. World Health Organization. The global burden of disease: 2004 update. 1st ed. World Health Organization; 2008.
4. RB Zipursky JH Meyer NP Verhoeff 2007 PET and SPECT imaging in psychiatric disorders Can J Psychiatry 52 3 146 157 17479522 (Pubitemid 46761957)
5. CJ Bench KJ Friston RG Brown RS Frackowiak RJ Dolan 1993 Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions Psychol Med 23 3 579 590 7901863 10.1017/S0033291700025368 1:STN:280:DyaK2c%2Flt1Cmug%3D%3D (Pubitemid 23268076)
6. LR Baxter Jr JM Schwartz ME Phelps JC Mazziotta BH Guze CE Selin, et al. 1989 Reduction of prefrontal cortex glucose metabolism common to three types of depression Arch Gen Psychiatry 46 3 243 250 2784046 1:CAS:528:DyaK3MXksVOitbg%3D (Pubitemid 19078261)
7. MS Buchsbaum J Wu BV Siegel E Hackett M Trenary L Abel, et al. 1997 Effect of sertraline on regional metabolic rate in patients with affective disorder Biol Psychiatry 41 1 15 22 8988791 10.1016/S0006-3223(96)00097-2 1:CAS:528:DyaK2sXhsVOiurw%3D (Pubitemid 27050641)
8. SH Kennedy KR Evans S Kruger HS Mayberg JH Meyer S McCann, et al. 2001 Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression Am J Psychiatry 158 6 899 905 11384897 10.1176/appi.ajp.158.6.899 1:STN:280:DC%2BD3MzhtFCguw%3D%3D (Pubitemid 32547619)
9. TA Kimbrell TA Ketter MS George JT Little BE Benson MW Willis, et al. 2002 Regional cerebral glucose utilization in patients with a range of severities of unipolar depression Biol Psychiatry 51 3 237 252 11839367 10.1016/S0006-3223(01)01216-1 1:CAS:528:DC%2BD38Xht1ajsbg%3D (Pubitemid 34142636)
10. T Hosokawa T Momose K Kasai 2009 Brain glucose metabolism difference between bipolar and unipolar mood disorders in depressed and euthymic states Prog Neuropsychopharmacol Biol Psychiatry 33 2 243 250 19100808 10.1016/j.pnpbp.2008.11.014 1:CAS:528:DC%2BD1MXit1Wqtbk%3D
11. LR Baxter Jr 1985 Phelps ME, Mazziotta JC, Schwartz JM, Gerner RH, Selin CE, et al. Cerebral metabolic rates for glucose in mood disorders. Studies with positron emission tomography and fluorodeoxyglucose F18 Arch Gen Psychiatry 42 5 441 447 3872649 (Pubitemid 15036838)
12. TA Ketter TA Kimbrell MS George RT Dunn AM Speer BE Benson, et al. 2001 Effects of mood and subtype on cerebral glucose metabolism in treatment-resistant bipolar disorder Biol Psychiatry 49 2 97 109 11164756 10.1016/S0006-3223(00)00975-6 1:CAS:528:DC%2BD3MXnsVSlug%3D%3D (Pubitemid 32119503)
13. JO Brooks III PW Wang JC Bonner AC Rosen JC Hoblyn SJ Hill, et al. 2009 Decreased prefrontal, anterior cingulate, insula, and ventral striatal metabolism in medication-free depressed outpatients with bipolar disorder J Psychiatr Res 43 3 181 188 18582900 10.1016/j.jpsychires.2008.04.015
14. WC Drevets JL Price JR Simpson Jr RD Todd T Reich M Vannier, et al. 1997 Subgenual prefrontal cortex abnormalities in mood disorders Nature 386 6627 824 827 9126739 10.1038/386824a0 1:CAS:528:DyaK2sXivVGjtrw%3D (Pubitemid 27181254)
15. JO Brooks III JC Hoblyn TA Ketter 2010 Metabolic evidence of corticolimbic dysregulation in bipolar mania Psychiatry Res 181 2 136 140 20080037 10.1016/j.pscychresns.2009.08.006 1:CAS:528:DC%2BC3cXhtlCnu74%3D
16. WC Drevets JL Price ME Bardgett T Reich RD Todd ME Raichle 2002 Glucose metabolism in the amygdala in depression: relationship to diagnostic subtype and plasma cortisol levels Pharmacol Biochem Behav 71 3 431 447 11830178 10.1016/S0091-3057(01)00687-6 1:CAS:528:DC%2BD38XhtVKrsrk%3D (Pubitemid 34126368)
17. L Mah CA Zarate Jr J Singh YF Duan DA Luckenbaugh HK Manji, et al. 2007 Regional cerebral glucose metabolic abnormalities in bipolar II depression Biol Psychiatry 61 6 765 775 17027930 10.1016/j.biopsych.2006.06.009 1:CAS:528:DC%2BD2sXisVWhtbo%3D (Pubitemid 46330241)
18. WC Drevets W Bogers ME Raichle 2002 Functional anatomical correlates of antidepressant drug treatment assessed using PET measures of regional glucose metabolism Eur Neuropsychopharmacol 12 6 527 544 12468016 10.1016/S0924-977X(02) 00102-5 1:CAS:528:DC%2BD38XptFeksb4%3D (Pubitemid 35408704)
19. HP Blumberg E Stern D Martinez S Ricketts J de Asis T White, et al. 2000 Increased anterior cingulate and caudate activity in bipolar mania Biol Psychiatry 48 11 1045 1052 11094137 10.1016/S0006-3223(00)00962-8 1:STN:280:DC%2BD3M%2Fms1OrsA%3D%3D
20. KJ Ressler HS Mayberg 2007 Targeting abnormal neural circuits in mood and anxiety disorders: from the laboratory to the clinic Nat Neurosci 10 9 1116 1124 17726478 10.1038/nn1944 1:CAS:528:DC%2BD2sXps1SgtbY%3D (Pubitemid 47339944)
21. M aan het Rot SJ Mathew DS Charney 2009 Neurobiological mechanisms in major depressive disorder CMAJ 180 3 305 313
22. SH Kennedy JZ Konarski ZV Segal MA Lau PJ Bieling RS McIntyre, et al. 2007 Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial Am J Psychiatry 164 5 778 788 17475737 10.1176/appi.ajp.164.5.778 (Pubitemid 46808533)
23. MS Milak RV Parsey L Lee MA Oquendo DM Olvet F Eipper, et al. 2009 Pretreatment regional brain glucose uptake in the midbrain on PET may predict remission from a major depressive episode after three months of treatment Psychiatry Res 173 1 63 70 19446443 10.1016/j.pscychresns.2008.09.004 1:CAS:528:DC%2BD1MXms1ait78%3D
24. JJ Schildkraut 1965 The catecholamine hypothesis of affective disorders: a review of supporting evidence Am J Psychiatry 122 5 509 522 5319766 1:STN:280:DyaF28%2FhvFCgsg%3D%3D
25. WC Drevets E Frank JC Price DJ Kupfer D Holt PJ Greer, et al. 1999 PET imaging of serotonin 1A receptor binding in depression Biol Psychiatry 46 10 1375 1387 10578452 10.1016/S0006-3223(99)00189-4 1:CAS:528:DyaK1MXntlensrs%3D
26. PA Sargent KH Kjaer CJ Bench EA Rabiner C Messa J Meyer, et al. 2000 Brain serotonin1A receptor binding measured by positron emission tomography with [11C]WAY-100635: effects of depression and antidepressant treatment Arch Gen Psychiatry 57 2 174 180 10665620 10.1001/archpsyc.57.2.174 1:CAS:528: DC%2BD3cXhtFyqsrs%3D (Pubitemid 30075269)
27. J Hirvonen H Karlsson J Kajander A Lepola J Markkula H Rasi-Hakala, et al. 2008 Decreased brain serotonin 5-HT1A receptor availability in medication-naive patients with major depressive disorder: an in-vivo imaging study using PET and [carbonyl-11C]WAY-100635 Int J Neuropsychopharmacol 11 4 465 476 17971260 10.1017/S1461145707008140 1:CAS:528:DC%2BD1cXmt1Kqt74%3D (Pubitemid 351744802)
28. WC Drevets ME Thase EL Moses-Kolko J Price E Frank DJ Kupfer, et al. 2007 Serotonin-1A receptor imaging in recurrent depression: replication and literature review Nucl Med Biol 34 7 865 877 17921037 10.1016/j.nucmedbio.2007. 06.008 1:CAS:528:DC%2BD2sXhtFeiu7%2FJ (Pubitemid 47505401)
29. CC Meltzer JC Price CA Mathis MA Butters SK Ziolko E Moses-Kolko, et al. 2004 Serotonin 1A receptor binding and treatment response in late-life depression Neuropsychopharmacology 29 12 2258 2265 15483563 10.1038/sj.npp. 1300556 1:CAS:528:DC%2BD2cXhtVSmsrfF (Pubitemid 39578918)
30. Z Bhagwagar EA Rabiner PA Sargent PM Grasby PJ Cowen 2004 Persistent reduction in brain serotonin1A receptor binding in recovered depressed men measured by positron emission tomography with [11C]WAY-100635 Mol Psychiatry 9 4 386 392 15042104 10.1038/sj.mp.4001401 1:CAS:528:DC%2BD2cXisVGmtLs%3D (Pubitemid 38534699)
31. RV Parsey MA Oquendo RT Ogden DM Olvet N Simpson YY Huang, et al. 2006 Altered serotonin 1A binding in major depression: a [carbonyl-C-11]WAY100635 positron emission tomography study Biol Psychiatry 59 2 106 113 16154547 10.1016/j.biopsych.2005.06.016 1:CAS:528:DC%2BD28XotVGksg%3D%3D (Pubitemid 43117499)
32. GM Sullivan RT Ogden MA Oquendo JS Kumar N Simpson YY Huang, et al. 2009 Positron emission tomography quantification of serotonin-1A receptor binding in medication-free bipolar depression Biol Psychiatry 66 3 223 330 19278673 10.1016/j.biopsych.2009.01.028 1:CAS:528:DC%2BD1MXotF2gu7Y%3D
33. JM Miller KG Brennan TR Ogden MA Oquendo GM Sullivan JJ Mann, et al. 2009 Elevated serotonin 1A binding in remitted major depressive disorder: evidence for a trait biological abnormality Neuropsychopharmacology 34 10 2275 2284 19458612 10.1038/npp.2009.54 1:CAS:528:DC%2BD1MXpvFygtr4%3D
34. PA Sargent EA Rabiner Z Bhagwagar L Clark P Cowen GM Goodwin, et al. 2010 5-HT(1A) receptor binding in euthymic bipolar patients using positron emission tomography with [carbonyl-(11)C]WAY-100635 J Affect Disord 123 1-3 77 80 19726088 10.1016/j.jad.2009.07.015 1:CAS:528:DC%2BC3cXlt1Sis7c%3D
35. RB Innis VJ Cunningham J Delforge M Fujita A Gjedde RN Gunn, et al. 2007 Consensus nomenclature for in vivo imaging of reversibly binding radioligands J Cereb Blood Flow Metab 27 9 1533 1539 17519979 10.1038/sj.jcbfm.9600493 1:CAS:528:DC%2BD2sXptlSqtrc%3D (Pubitemid 47301451)
36. G Fairchild MM Leitch CD Ingram 2003 Acute and chronic effects of corticosterone on 5-HT1A receptor-mediated autoinhibition in the rat dorsal raphe nucleus Neuropharmacology 45 7 925 934 14573385 10.1016/S0028-3908(03) 00269-7 1:CAS:528:DC%2BD3sXot1yrsbw%3D (Pubitemid 37297918)
37. F Biver D Wikler F Lotstra P Damhaut S Goldman J Mendlewicz 1997 Serotonin 5-HT2 receptor imaging in major depression: focal changes in orbito-insular cortex Br J Psychiatry 171 5 444 448 9463603 10.1192/bjp.171.5. 444 1:STN:280:DyaK1c7isVOltg%3D%3D (Pubitemid 27475842)
38. CC Meltzer JC Price CA Mathis PJ Greer MN Cantwell PR Houck, et al. 1999 PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders Am J Psychiatry 156 12 1871 1878 10588399 1:STN:280: DC%2BD3c%2FltlKhsg%3D%3D
39. MA Mintun YI Sheline SM Moerlein AG Vlassenko Y Huang AZ Snyder 2004 Decreased hippocampal 5-HT2A receptor binding in major depressive disorder: in vivo measurement with [18F]altanserin positron emission tomography Biol Psychiatry 55 3 217 224 14744461 10.1016/j.biopsych.2003.08.015 1:CAS:528:DC%2BD2cXmvF2ntA%3D%3D (Pubitemid 38117157)
40. YI Sheline MA Mintun DM Barch C Wilkins AZ Snyder SM Moerlein 2004 Decreased hippocampal 5-HT(2A) receptor binding in older depressed patients using [18F]altanserin positron emission tomography Neuropsychopharmacology 29 12 2235 2241 15367923 10.1038/sj.npp.1300555 1:CAS:528:DC%2BD2cXhtVSmsrfE (Pubitemid 39578915)
41. D Attar-Levy JL Martinot J Blin MH Dao-Castellana C Crouzel B Mazoyer, et al. 1999 The cortical serotonin2 receptors studied with positron-emission tomography and [18F]-setoperone during depressive illness and antidepressant treatment with clomipramine Biol Psychiatry 45 2 180 186 9951565 10.1016/S0006-3223(98)00007-9 1:CAS:528:DyaK1MXhtVequrs%3D (Pubitemid 29079448)
42. LN Yatham PF Liddle IS Shiah G Scarrow RW Lam MJ Adam, et al. 2000 Brain serotonin2 receptors in major depression: a positron emission tomography study Arch Gen Psychiatry 57 9 850 858 10986548 10.1001/archpsyc.57.9.850 1:CAS:528:DC%2BD3cXmvVWis7w%3D
43. JH Meyer S Kapur S Houle J DaSilva B Owczarek GM Brown, et al. 1999 Prefrontal cortex 5-HT2 receptors in depression: an [18F]setoperone PET imaging study Am J Psychiatry 156 7 1029 1034 10401447 1:STN:280:DyaK1MzivFKqsg%3D%3D (Pubitemid 29302795)
44. LN Yatham PF Liddle J Erez M Kauer-Sant'Anna RW Lam M Imperial, et al. 2010 Brain serotonin-2 receptors in acute mania Br J Psychiatry 196 1 47 51 20044660 10.1192/bjp.bp.108.057919
45. C Messa C Colombo RM Moresco C Gobbo L Galli G Lucignani, et al. 2003 5-HT(2A) receptor binding is reduced in drug-naive and unchanged in SSRI-responder depressed patients compared to healthy controls: a PET study Psychopharmacology (Berl) 167 1 72 78 1:CAS:528:DC%2BD3sXislyqsb0%3D (Pubitemid 36535294)
46. Z Bhagwagar R Hinz M Taylor S Fancy P Cowen P Grasby 2006 Increased 5-HT(2A) receptor binding in euthymic, medication-free patients recovered from depression: a positron emission study with [(11)C]MDL 100,907 Am J Psychiatry 163 9 1580 1587 16946184 10.1176/appi.ajp.163.9.1580 (Pubitemid 44465759)
47. JH Meyer S McMain SH Kennedy L Korman GM Brown JN DaSilva, et al. 2003 Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm Am J Psychiatry 160 1 90 99 12505806 10.1176/appi.ajp.160.1.90 (Pubitemid 36042431)
48. T Ichimiya T Suhara Y Sudo Y Okubo K Nakayama M Nankai, et al. 2002 Serotonin transporter binding in patients with mood disorders: a PET study with [11C](+)McN5652 Biol Psychiatry 51 9 715 722 11983185 10.1016/S0006-3223(01) 01351-8 1:CAS:528:DC%2BD38Xjt1SgtLg%3D (Pubitemid 34450807)
49. M Reivich JD Amsterdam DJ Brunswick CY Shiue 2004 PET brain imaging with [11C](+)McN5652 shows increased serotonin transporter availability in major depression J Affect Disord 82 2 321 327 15488265 10.1016/j.jad.2003.12.014 1:CAS:528:DC%2BD2cXos1ensLw%3D (Pubitemid 39370837)
50. RV Parsey RS Hastings MA Oquendo YY Huang N Simpson J Arcement, et al. 2006 Lower serotonin transporter binding potential in the human brain during major depressive episodes Am J Psychiatry 163 1 52 58 16390889 10.1176/appi.ajp.163.1.52 (Pubitemid 43050103)
51. MA Oquendo RS Hastings YY Huang N Simpson RT Ogden XZ Hu, et al. 2007 Brain serotonin transporter binding in depressed patients with bipolar disorder using positron emission tomography Arch Gen Psychiatry 64 2 201 208 17283287 10.1001/archpsyc.64.2.201 1:CAS:528:DC%2BD2sXisFylsLc%3D (Pubitemid 46220777)
52. JM Miller MA Oquendo RT Ogden JJ Mann RV Parsey 2008 Serotonin transporter binding as a possible predictor of one-year remission in major depressive disorder J Psychiatr Res 42 14 1137 1144 18331740 10.1016/j.jpsychires.2008.01.012
53. JH Meyer S Houle S Sagrati A Carella DF Hussey N Ginovart, et al. 2004 Brain serotonin transporter binding potential measured with carbon 11-labeled DASB positron emission tomography: effects of major depressive episodes and severity of dysfunctional attitudes Arch Gen Psychiatry 61 12 1271 1279 15583118 10.1001/archpsyc.61.12.1271 1:CAS:528:DC%2BD2MXjt1Kmtw%3D%3D (Pubitemid 39602843)
54. Z Bhagwagar N Murthy S Selvaraj R Hinz M Taylor S Fancy, et al. 2007 5-HTT binding in recovered depressed patients and healthy volunteers: a positron emission tomography study with [11C]DASB Am J Psychiatry 164 12 1858 1865 18056241 10.1176/appi.ajp.2007.06111933 (Pubitemid 351739239)
55. DM Cannon M Ichise D Rollis JM Klaver SK Gandhi DS Charney, et al. 2007 Elevated serotonin transporter binding in major depressive disorder assessed using positron emission tomography and [11C]DASB; comparison with bipolar disorder Biol Psychiatry 62 8 870 877 17678634 10.1016/j.biopsych.2007.03.016 1:CAS:528:DC%2BD2sXhtFerur3P (Pubitemid 47488222)
56. M Reimold A Batra A Knobel MN Smolka A Zimmer K Mann, et al. 2008 Anxiety is associated with reduced central serotonin transporter availability in unmedicated patients with unipolar major depression: a [11C]DASB PET study Mol Psychiatry 13 6 606 613 18268503 10.1038/sj.mp.4002149 1:CAS:528: DC%2BD1cXlvFOjt7s%3D 557 (Pubitemid 351704938)
57. P Rosa-Neto M Diksic H Okazawa M Leyton N Ghadirian S Mzengeza, et al. 2004 Measurement of brain regional alpha-[11C]methyl-L-tryptophan trapping as a measure of serotonin synthesis in medication-free patients with major depression Arch Gen Psychiatry 61 6 556 563 15184235 10.1001/archpsyc.61.6.556 1:CAS:528:DC%2BD2cXlsFCju7c%3D (Pubitemid 38747310)
58. BN Frey I Skelin Y Sakai M Nishikawa M Diksic 2010 Gender differences in alpha-[(11)C]MTrp brain trapping, an index of serotonin synthesis, in medication-free individuals with major depressive disorder: a positron emission tomography study Psychiatry Res 183 2 157 166 20630715 10.1016/j.pscychresns. 2010.05.005 1:CAS:528:DC%2BC3cXpt12hs7g%3D
59. T Suhara K Nakayama O Inoue H Fukuda M Shimizu A Mori, et al. 1992 D1 dopamine receptor binding in mood disorders measured by positron emission tomography Psychopharmacology (Berl) 106 1 14 18 10.1007/BF02253582 1:CAS:528:DyaK38XisFent7w%3D
60. DD Dougherty AA Bonab WE Ottowitz E Livni NM Alpert SL Rauch, et al. 2006 Decreased striatal D1 binding as measured using PET and [11C]SCH 23,390 in patients with major depression with anger attacks Depress Anxiety 23 3 175 177 16528700 10.1002/da.20168 1:CAS:528:DC%2BD28XlvFamtLg%3D (Pubitemid 43727148)
61. DM Cannon JM Klaver SA Peck D Rallis-Voak K Erickson WC Drevets 2009 Dopamine type-1 receptor binding in major depressive disorder assessed using positron emission tomography and [11C]NNC-112 Neuropsychopharmacology 34 5 1277 1287 18946469 10.1038/npp.2008.194 1:CAS:528:DC%2BD1MXjtFentLo%3D
62. AJ Montgomery P Stokes Y Kitamura PM Grasby 2007 Extrastriatal D2 and striatal D2 receptors in depressive illness: pilot PET studies using [11C]FLB 457 and [11C]raclopride J Affect Disord 101 1-3 113 122 17197036 10.1016/j.jad.2006.11.010 1:CAS:528:DC%2BD2sXmtlSntrc%3D (Pubitemid 46879919)
63. J Hirvonen H Karlsson J Kajander J Markkula H Rasi-Hakala K Nagren, et al. 2008 Striatal dopamine D2 receptors in medication-naive patients with major depressive disorder as assessed with [11C]raclopride PET Psychopharmacology (Berl) 197 4 581 590 10.1007/s00213-008-1088-9 1:CAS:528:DC%2BD1cXkt1yht74%3D
64. JH Meyer HE McNeely S Sagrati A Boovariwala K Martin NP Verhoeff, et al. 2006 Elevated putamen D(2) receptor binding potential in major depression with motor retardation: an [11C]raclopride positron emission tomography study Am J Psychiatry 163 9 1594 1602 16946186 10.1176/appi.ajp.163.9.1594 (Pubitemid 44465761)
65. JH Meyer S Kruger AA Wilson BK Christensen VS Goulding A Schaffer, et al. 2001 Lower dopamine transporter binding potential in striatum during depression Neuroreport 12 18 4121 4125 11742250 10.1097/00001756-200112210-00052 1:CAS:528:DC%2BD38Xjsl2rsQ%3D%3D (Pubitemid 33152464)
66. P Remy M Doder A Lees N Turjanski D Brooks 2005 Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system Brain 128 6 1314 1322 15716302 10.1093/brain/awh445 (Pubitemid 40826185)
67. LN Yatham PF Liddle RW Lam IS Shiah C Lane AJ Stoessl, et al. 2002 PET study of the effects of valproate on dopamine D(2) receptors in neuroleptic- and mood-stabilizer-naive patients with nonpsychotic mania Am J Psychiatry 159 10 1718 1723 12359678 10.1176/appi.ajp.159.10.1718
68. V Bragulat ML Paillere-Martinot E Artiges V Frouin JB Poline JL Martinot 2007 Dopaminergic function in depressed patients with affective flattening or with impulsivity: [18F]fluoro-L-dopa positron emission tomography study with voxel-based analysis Psychiatry Res 154 2 115 124 17306513 10.1016/j. pscychresns.2006.07.002 1:CAS:528:DC%2BD2sXkt1Wmu7k%3D
69. DM Cannon RE Carson AC Nugent WC Eckelman DO Kiesewetter J Williams, et al. 2006 Reduced muscarinic type 2 receptor binding in subjects with bipolar disorder Arch Gen Psychiatry 63 7 741 747 16818863 10.1001/archpsyc.63.7.741 1:CAS:528:DC%2BD28XnsFGls78%3D
70. M Kano S Fukudo A Tashiro A Utsumi D Tamura M Itoh, et al. 2004 Decreased histamine H1 receptor binding in the brain of depressed patients Eur J Neurosci 20 3 803 810 15255990 10.1111/j.1460-9568.2004.03540.x (Pubitemid 39036940)
71. UM Klumpers DJ Veltman ML Drent R Boellaard EF Comans G Meynen, et al. 2010 Reduced parahippocampal and lateral temporal GABAA-[11C]flumazenil binding in major depression: preliminary results Eur J Nucl Med Mol Imaging 37 3 565 574 19890631 10.1007/s00259-009-1292-9 1:CAS:528:DC%2BC3cXhvFKgsbg%3D
72. JH Meyer 2007 Imaging the serotonin transporter during major depressive disorder and antidepressant treatment J Psychiatry Neurosci 32 2 86 102 17353938 (Pubitemid 46597955)
73. RM Moresco C Colombo F Fazio A Bonfanti G Lucignani C Messa, et al. 2000 Effects of fluvoxamine treatment on the in vivo binding of [F-18]FESP in drug naive depressed patients: a PET study Neuroimage 12 4 452 465 10988039 10.1006/nimg.2000.0619 1:STN:280:DC%2BD3M%2FhsVSruw%3D%3D
74. EL Moses-Kolko JC Price ME Thase CC Meltzer DJ Kupfer CA Mathis, et al. 2007 Measurement of 5-HT1A receptor binding in depressed adults before and after antidepressant drug treatment using positron emission tomography and [11C]WAY-100635 Synapse 61 7 523 530 17447260 10.1002/syn.20398 1:CAS:528:DC%2BD2sXlsV2rsro%3D (Pubitemid 46753971)
75. H Karlsson J Hirvonen J Kajander J Markkula H Rasi-Hakala JK Salminen, et al. 2010 Psychotherapy increases brain serotonin 5-HT1A receptors in patients with major depressive disorder Psychol Med 40 3 523 528 19903365 10.1017/S0033291709991607 1:STN:280:DC%2BC3c%2Flslyntg%3D%3D
76. Hirvonen J, Hietala J, Kajander J, Markkula J, Rasi-Hakala H, Salminen J, et al. Effects of antidepressant drug treatment and psychotherapy on striatal and thalamic dopamine D2/3 receptors in major depressive disorder studied with [11C]raclopride PET. J Psychopharmacol 2010; doi: 10.1177/0269881110376691
77. Y Kuroda N Motohashi H Ito S Ito A Takano T Nishikawa, et al. 2006 Effects of repetitive transcranial magnetic stimulation on [11C]raclopride binding and cognitive function in patients with depression J Affect Disord 95 1-3 35 42 16781779 10.1016/j.jad.2006.03.029 1:CAS:528:DC%2BD28Xps1Wnu70%3D (Pubitemid 46107029)
78. LN Yatham PF Liddle IS Shiah RW Lam E Ngan G Scarrow, et al. 2002 PET study of [(18)F]6-fluoro-L-dopa uptake in neuroleptic- and mood-stabilizer-naive first-episode nonpsychotic mania: effects of treatment with divalproex sodium Am J Psychiatry 159 5 768 774 11986130 10.1176/appi.ajp.159.5.768 (Pubitemid 34465050)
79. LN Yatham PF Liddle RW Lam MJ Adam K Solomons M Chinnapalli, et al. 2005 A positron emission tomography study of the effects of treatment with valproate on brain 5-HT2A receptors in acute mania Bipolar Disord 7 Suppl 5 53 57 16225561 10.1111/j.1399-5618.2005.00252.x 1:CAS:528:DC%2BD28Xot1egsA%3D%3D (Pubitemid 43013461)
80. J Kalbitzer D Erritzoe KK Holst FA Nielsen L Marner S Lehel, et al. 2010 Seasonal changes in brain serotonin transporter binding in short serotonin transporter linked polymorphic region-allele carriers but not in long-allele homozygotes Biol Psychiatry 67 11 1033 1039 20110086 10.1016/j.biopsych.2009.11. 027 1:CAS:528:DC%2BC3cXlvVWltL8%3D